Results 291 to 300 of about 240,898 (360)

Exploring market dynamics of biological including biosimilar treatments for retinal diseases in Europe: An interrupted time‐series analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To assess the impact of biosimilar ranibizumab and on‐patent faricimab market entry on pricing and utilization trends and describe national variation in off‐label bevacizumab use in Europe. Methods Interrupted time series analysis of quarterly sales data (Q1 2018–Q2 2024) in 11 European countries evaluated ranibizumab utilization and ...
Elif Car   +3 more
wiley   +1 more source

Tick‐Borne Encephalitis (TBE) Vaccine in the National Immunisation Programme—For Whom, When and Where?

open access: yesActa Paediatrica, EarlyView.
ABSTRACT The incidence of Tick‐borne encephalitis (TBE) cases has increased. The presumed location of transmission of Tick‐borne encephalitis virus (TBEV) has been expanding increasingly in the western parts of Europe during the past decade. There has also been an increased incidence of surveillance‐reported TBE cases in southern Sweden and southern ...
H. H. Askling, D. Zavadska
wiley   +1 more source

Epidemiological and clinical characteristics of hereditary angioedema in the Baltic states. [PDF]

open access: yesFront Immunol
Kurjane N   +11 more
europepmc   +1 more source

Unmet healthcare needs and volunteering during the COVID‐19 pandemic in the European Union: Exploring heterogeneity in age classes

open access: yesAnnals of Public and Cooperative Economics, EarlyView.
Abstract This paper investigates the relationship between volunteering and unmet healthcare needs (UHN) during the COVID‐19 pandemic in EU countries, focusing on different age groups. Previous studies have shown that younger people are more likely to report UHN than older people in the EU.
Nunzia Nappo   +2 more
wiley   +1 more source

Parry-Romberg Syndrome Associated With En Coup De Sabre: A Clinical Case Report. [PDF]

open access: yesCureus
Dragunaite G   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy